ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/18/2022
Back to search
Official data from USPTO
ONKO-INNATE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ONKO-INNATE
ST13
US500000079292390Class
5, 42
Filing
79292390
Registration
6617149
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
09/18/2022
Trademark type
Word
Nice classes
5, 42
Filing date
07/23/2020
Registration date
01/18/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/18/2022
Last transaction
01/18/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
LINDEMYER, ANKHI
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
oNKo-innate Pty Ltd
Representatives
Andrew S. Ehard Merchant & Gould P.C.
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical drugs for the treatment of cancer and immune cell related disorders; pharmaceutical preparations for the treatment of cancer and immune cell related disorders; stem cells for medical purposes; living cells for medical use; pharmaceutical and biological preparations for the treatment of cancer; biological preparations for medical use for the treatment of cancer and immune cell related disorders; chemicals for pharmaceutical use for the treatment of cancer and immune cell related disorders
Class 42
Scientific research; pharmaceutical researchdevelopment and testing services; scientific researchpreparation of scientific reports; advisory services relating to immunological product development and testing; scientific researchdesignanalysis and testing of pharmaceutical products; conducting scientific and medical research and clinical trials; scientific research in the field of immunology and cancer treatment; scientific research and testing in the field of natural killer cells; provision of scientific information in the field of immunologycancer treatment and the treatment of immune cell related disorders; scientific and technical analysisscientific researchanalysis and testing in the field of immunologycancer treatment and the treatment of immune cell related disorders; scientific research consultancy in the field of immunologycancer treatment and the treatment of immune cell related disorders; scientific research in the field of pharmacy; medical research; research and development of products; research relating to pharmaceuticals
Publications
History of USPTO decisions and trademark events.
32 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/14/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/18/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/28/2022
FIMP
FINAL DISPOSITION PROCESSED
06/27/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04/18/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
01/18/2022
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
12/12/2021
DOCK
ASSIGNED TO EXAMINER
11/03/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
09/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/03/2021
PUBO
PUBLISHED FOR OPPOSITION
08/03/2021
GPNX
NOTIFICATION PROCESSED BY IB
08/01/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/14/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/14/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/28/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/21/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/20/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/20/2021
ATRV
ATTORNEY REVIEW COMPLETED
04/06/2021
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
03/24/2021
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
02/13/2021
RFNT
REFUSAL PROCESSED BY IB
12/20/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/01/2020
RFRR
REFUSAL PROCESSED BY MPU
12/01/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/14/2020
CNRT
NON-FINAL ACTION WRITTEN
11/13/2020
DOCK
ASSIGNED TO EXAMINER
11/09/2020
MAFR
APPLICATION FILING RECEIPT MAILED
09/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/28/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/27/2020
Continuous trademark protection
Get notified about every new filing that threatens ONKO-INNATE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.